Anti-flocculation submicron emulsion as well as preparation method and application thereof
Through the preparation of plant-based proteolytic hydrolysate-EGCG complex, the problem of poor solubility and emulsification characteristics of plant proteins is solved, and an anti-flocculation submicron emulsion is formed, which improves the stability and application range of the emulsion.
Patent Information
- Application Number
- CN202410954113.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-07-16
AI Technical Summary
Due to its poor solubility and poor emulsification characteristics, plant proteins are limited in widespread use in foods, and the emulsions are prone to flocculation, affecting the texture and stability of the product.
采用植物基蛋白水解物-EGCG复合物,通过碱热处理生成植物基蛋白水解物,并与EGCG进行共价反应,形成植物基蛋白水解物-EGCG复合物,通过剪切和高压均质处理制备抗絮凝亚微米乳液。
It improves the solubility, emulsification characteristics and antioxidant ability of plant-based proteins, reduces the degree of flocculation of the emulsion, enhances its application potential in food and cosmetics, and improves storage stability.
Smart Images

Figure CN118902113A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of food engineering, and in particular relates to a deflocculating submicron emulsion and a preparation method and application thereof. Background Art
[0002] Plant proteins, such as soy protein, pea protein, and chickpea protein, have been studied as substitutes for animal proteins in various foods due to their high yield, low cost, balanced amino acid structure, high lysine content, and rich nutritional value. In addition, plant proteins have been reported to exhibit some biological activities, such as antioxidant activity, lowering blood pressure, and regulating intestinal flora. However, the widespread application of plant proteins in food is still limited due to their poor solubility. Specifically, plant proteins have relatively high globulin content, such as soybean legumin and conglycinin, which leads to the extraction methods used to separate them usually promoting protein denaturation and aggregation. In addition, the poor solubility of plant proteins also affects their emulsifying properties. Hydrolyzing proteins to obtain protein hydrolysates can stretch the structure of proteins and expose reactive groups, thereby enhancing their functional properties such as solubility and emulsifying activity.
[0003] Emulsion refers to a heterogeneous liquid dispersion system formed by one phase of liquid dispersed in another phase of liquid in the form of tiny droplets. It has been widely used in the food industry. However, the flocculation problem of emulsions remains a major challenge in their application. Flocculation refers to the aggregation of small droplets in the emulsion to form larger aggregates, which leads to a decrease in the stability of the emulsion and affects the texture and appearance of the product. Flocculation is usually caused by uneven particle size distribution, insufficient charge on the droplet surface, changes in environmental conditions, and improper type and dosage of emulsifiers. Summary of the invention
[0004] The main purpose of the present invention is to provide a deflocculating submicron emulsion and a preparation method and application thereof, so as to overcome the deficiencies of the prior art.
[0005] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention includes:
[0006] The embodiment of the present invention provides a method for preparing a deflocculated submicron emulsion, which comprises:
[0007] A mixed solution containing a plant-based protein hydrolysate-EGCG complex and water is used as the aqueous phase, and walnut oil is used as the oil phase;
[0008] Furthermore, the oil phase is mixed with the water phase and subjected to shearing and high-pressure homogenization treatment to obtain a deflocculated submicron emulsion.
[0009] The embodiment of the present invention also provides a deflocculated submicron emulsion prepared by the aforementioned preparation method.
[0010] The embodiment of the present invention also provides the use of the aforementioned anti-flocculation submicron emulsion in liquid emulsified food.
[0011] Compared with the prior art, the present invention has the following beneficial effects:
[0012] (1) The present invention uses plant-based protein as raw material, which is cheap and readily available, thus expanding the application scope and approach of plant-based protein;
[0013] (2) The present invention avoids the use of expensive centrifuges or ultrasonic machines without introducing any organic reagents. Only common heating equipment and pH meters or pH test papers are required during the preparation process. Protein hydrolysates are obtained only through hot alkali treatment. This method does not require chemical crosslinking agents, is simple to operate, and has mild treatment conditions. After hot alkali treatment, the protein peptide chains are broken to generate plant-based protein hydrolysates, whose reactive groups are exposed, which is conducive to covalent grafting reaction with EGCG, thereby increasing the grafting degree between plant-based protein and EGCG, thereby enhancing its functional properties;
[0014] (3) The present invention provides a method for preparing a plant-based protein hydrolysate-EGCG complex. By introducing natural polyphenol EGCG, the obtained protein covalent complex has better solubility and emulsification properties. At the same time, the protein hydrolysate is endowed with good antioxidant capacity. The complex has a wide range of uses in the fields of food and cosmetics.
[0015] (4) The walnut emulsion stabilized by the plant-based protein hydrolyzate-EGCG complex prepared by the present invention is a submicron emulsion with a low degree of flocculation, and the submicron emulsion has good storage stability. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0017] Figure 1 It is a preparation flow chart of the anti-flocculation walnut oil submicron emulsion prepared by the plant-based protein hydrolyzate-EGCG complex in Examples 1, 2 and 3 of the present invention;
[0018] Figure 2 It is a schematic diagram of the grafting rate results of the plant-based protein-EGCG complex and the plant-based protein hydrolysate-EGCG complex in Example 1, Example 2, Example 3, Comparative Example 1, Comparative Example 4, and Comparative Example 7 of the present invention;
[0019] Figure 3 Scanning electron microscope results of plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 of the present invention;
[0020] Figure 4A-4C This is a schematic diagram of the surface hydrophobicity results of plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 of the present invention, Figure 4A Soy protein, Figure 4B For pea protein, Figure 4C For chickpea protein;
[0021] Figure 5A-5C This is a schematic diagram of the solubility results of plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 of the present invention, Figure 5A Soy protein, Figure 5B For pea protein, Figure 5C For chickpea protein;
[0022] Figure 6A-6C This is a schematic diagram of the thermal stability results of the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9 of the present invention, Fig. 6A Soy protein, Figure 6B For pea protein, Figure 6C For chickpea protein;
[0023] Figure 7A-7C It is a schematic diagram of the test results of the emulsification activity index (EAI) and the emulsification stability index (ESI) of the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9 of the present invention, Fig. 7A Soy protein, Figure 7B For pea protein, Figure 7C For chickpea protein;
[0024] Figure 8A-8C This is a schematic diagram of the antioxidant activity (ABTS free radical scavenging rate) test results of the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9 of the present invention, Fig. 8A Soy protein, Figure 8B For pea protein, Figure 8C For chickpea protein.
[0025] Figure 9A-9I Result graphs of average particle size, flocculation index and particle size distribution of different emulsions of walnut oil emulsions stabilized by plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex and plant-based protein hydrolysate-EGCG complex in Examples 1-3, Comparative Example 1, Comparative Example 4 and Comparative Example 7 of the present invention dispersed in distilled water and 1% SDS solution;
[0026] Fig.10 The emulsion morphology of the anti-flocculated walnut oil submicron emulsion stabilized by plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, and plant-based protein hydrolysate-EGCG complex in Examples 1-3, Comparative Example 1, Comparative Example 4, and Comparative Example 7 of the present invention after storage in a refrigerator at 4°C. DETAILED DESCRIPTION
[0027] In view of the defects of the prior art, the inventor of this case has proposed the technical solution of the present invention after long-term research and extensive practice. The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0028] Specifically, as one aspect of the technical solution of the present invention, a method for preparing a deflocculated submicron emulsion includes:
[0029] A mixed solution containing a plant-based protein hydrolysate-EGCG complex and water is used as the aqueous phase, and walnut oil is used as the oil phase;
[0030] Furthermore, the oil phase is mixed with the water phase and subjected to shearing and high-pressure homogenization treatment to obtain a deflocculated submicron emulsion.
[0031] In some preferred embodiments, the plant-based protein hydrolysate is mixed with EGCG, and the plant-based protein hydrolysate-EGCG complex is obtained by alkali induction.
[0032] In some preferred embodiments, the preparation method specifically comprises:
[0033] dispersing the plant-based protein hydrolysate-EGCG complex in water to form a plant-based protein hydrolysate-EGCG complex dispersion as an aqueous phase;
[0034] Also, walnut oil as the oil phase is slowly added to the water phase under stirring conditions, and sheared at 8000-10000 rpm (eg 9000 rpm) for 2-4 min (eg 3 min), and then homogenized by a high-pressure homogenizer to obtain a deflocculated submicron emulsion.
[0035] Furthermore, the homogenization treatment conditions include: fixed circulation three times at 40-60MPa.
[0036] Furthermore, the concentration of the plant-based protein hydrolysate-EGCG complex in the plant-based protein hydrolysate-EGCG complex dispersion is 0.5-1.5 wt %.
[0037] Furthermore, the volume ratio of the water phase to the oil phase is 95:5 to 85:15.
[0038] Furthermore, the volume ratio of the water phase to the oil phase is 70:30-90:10.
[0039] In some preferred embodiments, the method for preparing the plant-based protein hydrolysate-EGCG complex comprises:
[0040] The plant-based protein is subjected to a heat-alkali treatment to obtain a plant-based protein hydrolyzate;
[0041] The plant-based protein hydrolysate is mixed with EGCG and subjected to an alkali induction treatment to obtain a plant-based protein hydrolysate-EGCG complex.
[0042] In some preferred embodiments, the method for preparing the plant-based protein hydrolysate-EGCG complex comprises:
[0043] Dispersing the plant-based protein in water and stirring overnight to fully hydrate it to obtain a plant-based protein dispersion;
[0044] And, the pH value of the plant-based protein dispersion is adjusted to 11.5-12.5, and heated to 75-85° C. in a water bath and maintained for 25-35 minutes, and then cooled and adjusted to a pH value of 6.5-7.5 to obtain a plant-based protein hydrolyzate.
[0045] Furthermore, the concentration of the plant protein in the plant-based protein dispersion is 0.5-1.5 w / v %.
[0046] Furthermore, the plant-based protein includes any one or more combinations of soy protein isolate, pea protein isolate, and chickpea protein isolate, but is not limited thereto.
[0047] In some preferred embodiments, the preparation method of the plant-based protein hydrolysate-EGCG complex comprises: mixing a plant-based protein hydrolysate solution with an EGCG solution and adjusting the pH value to 8.5-9.5, stirring the mixture at 200-400 rpm for 24 hours in the dark, and then purifying and drying the mixture to obtain a plant-based protein hydrolysate-EGCG complex.
[0048] Furthermore, the particle size of the plant-based protein hydrolysate-EGCG complex is 0.588-1.266 μm.
[0049] Furthermore, the volume ratio of the plant-based protein hydrolyzate solution to the EGCG solution is 10:2-10:4.
[0050] Furthermore, the purification treatment is carried out by dialysis, wherein the dialysis temperature is 4-8°C; and the molecular weight of the dialysis bag used in the dialysis is 8000-16000Da.
[0051] Furthermore, the drying process is performed by vacuum freeze drying.
[0052] In some preferred embodiments, the volume ratio of the plant-based protein to EGCG is 10:3.
[0053] In some more specific embodiments, the preparation method of the plant-based protein hydrolysate-EGCG complex comprises the following steps: obtaining a plant-based protein hydrolysate solution by hot alkali treatment, mixing the plant-based protein hydrolysate solution and the EGCG solution in equal volumes, adjusting the pH, stirring and reacting at 300 rpm in the dark for 24 hours, dialyzing the reacted sample for 72 hours and performing vacuum freeze-drying to obtain a plant-based protein hydrolysate-EGCG complex.
[0054] Further, the plant-based protein is dispersed in water and stirred at 300 rpm overnight to be fully hydrated to obtain a plant-based protein dispersion, the pH value of the plant-based protein dispersion is adjusted to 11.5-12.5 to place it in an alkaline environment, and then heated to 75-85°C in a water bath for 25-35 minutes and then cooled to adjust the pH to 7.0 to obtain the plant-based protein hydrolysate and store it at 0-4°C.
[0055] Further, EGCG was dispersed in water to form an EGCG solution, the plant-based protein hydrolysate solution was mixed with the EGCG solution and the pH value of the reaction system was maintained at 9.0, and the reaction was carried out in a dark environment for 24 hours to obtain a plant-based protein hydrolysate-EGCG complex, which was dialyzed, dried and stored at 0-4°C.
[0056] Another aspect of the embodiments of the present invention further provides a deflocculated submicron emulsion prepared by the aforementioned preparation method.
[0057] Another aspect of the embodiments of the present invention further provides use of the aforementioned deflocculated submicron emulsion in liquid emulsified food.
[0058] The anti-flocculation submicron emulsion of the present invention has good application prospects in the fields of liquid emulsified food, nutritional enhancers, embedding of bioactive substances, delivery of nutrients or controlled release of drugs.
[0059] The technical solution of the present invention is further described in detail below in conjunction with several preferred embodiments and drawings. This embodiment is implemented on the premise of the technical solution of the invention, and a detailed implementation method and specific operation process are given, but the protection scope of the present invention is not limited to the following embodiments.
[0060] The pea protein isolate (purity 76.63%) and soy protein isolate (purity 75.03%) used in the following examples were purchased from Shanghai Yuanye Co., Ltd., and the chickpea protein isolate (purity 72.45%) was purchased from Shaanxi Jinkangtai Biotechnology Co., Ltd.; epigallocatechin gallate was purchased from Beijing Beishi Zongheng Technology Development Co., Ltd., and the purity was ≥98%; ferric chloride hexahydrate reagent was purchased from Tianjin Komio Chemical Reagent Co., Ltd.; medium chain triglycerides (MCT) were purchased from Xi'an Haisifu Biotechnology Co., Ltd.; other reagents were all analytical grade (AR).
[0061] Example 1 DETAILED DESCRIPTION
[0063] 1. Preparation of alkali-heat treated soy protein and modified soy protein-EGCG complex
[0064] (1) Alkali heat treatment of soybean protein
[0065] At room temperature, 1.0 g of soybean protein (SPI) was dissolved in 100 mL of distilled water and stirred for hydration overnight. The dissolved protein dispersion was adjusted to pH 12.0 using 1 M NaOH solution to place the protein dispersion in an alkaline environment, and then heated in a water bath at 80°C for 30 min. After cooling, the pH was adjusted to 7.0 to obtain an alkali-heat-treated soybean protein hydrolyzate.
[0066] (2) Preparation of protein hydrolysate-EGCG complex
[0067] The alkali-heat-treated soy protein hydrolysate obtained in step (1) was mixed with EGCG solution (10 mg / mL) at a ratio of protein hydrolysate solution: EGCG solution = 10:3 (V / V), and the pH of the mixed solution was adjusted to 9.0, and the mixture was reacted at 26°C in the dark for 24 hours. After treatment, all samples were dialyzed in a dialysis bag (8000-14000Da) at 4°C for 48 hours to remove free EGCG. During this period, clean deionized water was replaced every 6 hours. All samples after dialysis were freeze-dried and stored in a -20°C refrigerator. The treated samples were recorded as TSPI-EGCG.
[0068] (3) Preparation of walnut oil emulsion
[0069] The plant-based protein hydrolysate-EGCG complex prepared above is used to prepare a stable O / W walnut oil emulsion, and the specific steps include:
[0070] The plant-based protein hydrolysate-EGCG complex dispersion is the water phase, and the walnut oil is the oil phase. The concentration of the plant-based protein hydrolysate-EGCG complex in the water phase is 1.0wt%; the volume fraction of the oil phase is 10%. The oil phase is slowly added to the water phase under the stirring of a high-speed emulsifying homogenizer, sheared at 9,000rpm for 3 minutes, and then processed 3 times by a high-pressure homogenizer at 50MPa to prepare a walnut oil submicron emulsion. The emulsion is then stored at 0-4°C.
[0071] Example 2
[0072] The difference between Example 2 and Example 1 is that in step (1), 10 mg / mL pea protein dispersion (PPI) is used for alkaline heat treatment and then reacted with EGCG, and the other conditions are consistent with Example 1. The prepared complex is named TPPI-EGCG.
[0073] Example 3
[0074] The difference between Example 3 and Example 1 is that in step (1), 10 mg / mL chickpea protein dispersion (CPI) is used for alkaline heat treatment and then reacted with EGCG, and the other conditions are consistent with Example 1. The prepared complex is named TCPI-EGCG.
[0075] Comparative Example 1
[0076] The same as Example 1, except that the soy protein dispersion that has not been subjected to alkali heat treatment is used to react with the EGCG solution, and the prepared composite is named SPI-EGCG.
[0077] Comparative Example 2
[0078] The same as Example 1, except that a soy protein dispersion that has not been subjected to alkali heat treatment is mixed with the EGCG solution, the pH is adjusted to 7.0, and then dialyzed and freeze-dried. The prepared complex is named SPI-EGCG-MIX.
[0079] Comparative Example 3
[0080] The same as Example 1, except that the soy protein hydrolyzate solution after alkali heat treatment was mixed with the EGCG solution, the pH was adjusted to 7.0, and then dialyzed directly and freeze-dried. The prepared complex was named TSPI-EGCG-MIX.
[0081] Comparative Example 4
[0082] The same as Example 2, except that the pea protein dispersion that has not been subjected to alkali heat treatment is used to react with the EGCG solution, and the prepared complex is named PPI-EGCG.
[0083] Comparative Example 5
[0084] The same as Example 2, except that a pea protein dispersion that has not been subjected to alkali heat treatment is mixed with the EGCG solution, the pH is adjusted to 7.0, and then dialyzed and freeze-dried. The prepared complex is named PPI-EGCG-MIX.
[0085] Comparative Example 6
[0086] The same as Example 2, except that the pea protein hydrolyzate solution after alkaline heat treatment was mixed with the EGCG solution, the pH was adjusted to 7.0, and then dialyzed directly and freeze-dried. The prepared complex was named TPPI-EGCG-MIX.
[0087] Comparative Example 7
[0088] The same as Example 3, except that the chickpea protein dispersion that has not been subjected to alkali heat treatment is used to react with the EGCG solution, and the prepared composite is named CPI-EGCG.
[0089] Comparative Example 8
[0090] The same as Example 3, except that a chickpea protein dispersion that has not been subjected to alkali heat treatment is mixed with the EGCG solution, the pH is adjusted to 7.0, and then dialyzed and freeze-dried. The prepared complex is named CPI-EGCG-MIX.
[0091] Comparative Example 9
[0092] The same as Example 3, except that the chickpea protein hydrolyzate solution after alkali heat treatment was mixed with the EGCG solution, the pH was adjusted to 7.0, and then dialyzed and freeze-dried. The prepared complex was named TCPI-EGCG-MIX.
[0093] 2. Protein-EGCG grafting degree:
[0094] Prepare 0.2 mol / L Folin phenol reagent, mix 0.5 mL 1 mg / mL protein-EGCG sample with 2.5 mL Folin phenol reagent. Place in the dark for 5 min, add 2 mL of sodium carbonate solution (7.5%, w / v), vortex for 2 min, and then place in the dark for 2 h. The absorbance of the mixed solution at 760 nm was measured by UV-visible spectrophotometer, and plant-based protein that did not react with EGCG was used as a blank control. According to the EGCG standard curve, the EGCG content in each composite sample was determined. The grafting degree was calculated using the following formula:
[0095] Grafting degree (%) = (C / C0) × 100
[0096] Wherein, C is the EGCG content in the complex, and C0 is the EGCG content in the reactant before dialysis.
[0097] Figure 2 It is the EGCG grafting rate of the plant-based protein hydrolysate-EGCG complex and the plant-based protein-EGCG complex in Example 1, Example 2, Example 3, Comparative Example 1, Comparative Example 4, and Comparative Example 7. Under the same environment, SPI, PPI, CPI and TSPI, TPPI, TCPI with the same protein content form covalent complexes with equal amounts of EGCG. The results show that the binding rates of TSPI, TPPI, TCPI with EGCG are 77.35%, 75.51%, and 74.19%, respectively, which are 35%, 46%, and 19% higher than SPI, PPI, and CPI, respectively. Obviously, the binding rates of TSPI, TPPI, and TCPI are higher, which may be related to the change in protein structure and the exposure of reactive sites. Hot alkali treatment causes the protein to hydrolyze to form protein hydrolysate, resulting in the unfolding of the protein structure, increasing the number of free sulfhydryl groups and the content of free amino groups, so that TSPI, TPPI, and TCPI have more reactive groups, which can react more easily with EGCG, thereby increasing the degree of grafting.
[0098] 3. Microstructure of the composite
[0099] The microstructure of different samples was observed by scanning electron microscopy. The freeze-dried samples were fixed on double-sided tape, coated with a 30nm gold sputtering coating, made conductive for 45s, and observed by scanning at 5kV.
[0100] The microstructures of the plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 were observed using a scanning electron microscope. The test results are as follows: Figure 3 As shown. SPI, PPI, and CPI all contain globular proteins of varying sizes with slightly concave surfaces. Compared with SPI, PPI, and CPI, TSPI, TPPI, and TCPI present cleaved protein fragments, indicating that the protein was hydrolyzed under alkali heat treatment to generate protein hydrolysates. The morphology of SPI-EGCG-MIX, PPI-EGCG-MIX, CPI-EGCG-MIX and SPI, PPI, CPI, and TSPI-EGCG-MIX, TPPI-EGCG-MIX, TCPI-EGCG-MIX and TSPI, TPPI, and TCPI are very similar, indicating that the non-covalent binding of EGCG to protein has little effect on the overall structure of the protein. However, due to electrostatic interactions, when the concentration of EGCG is high, EGCG can act as a ligand to connect proteins and / or protein-EGCG complexes to form dimers and aggregates of proteins. From the SEM images, it can be seen that EGCG acts as a ligand to connect proteins to form insoluble particles, which leads to protein precipitation. In contrast, the particles of the covalent complexes were larger and more irregular in shape than those in SPI, PPI, and CPI, indicating that the covalent reaction changes the particle size and morphology of the protein. These results suggest that the covalent reaction with EGCG changes the size and morphology of the protein-based particles. The increase in particle size is partly attributed to the formation of protein aggregates linked together by EGCG.
[0101] 4. Particle size and zeta potential of the complex
[0102] The average particle size, polydispersity index (PDI) and Zeta-potential of the samples were measured using a Malvern particle size analyzer. All measurements were performed at 25 ° C, and each sample was measured three times under the same conditions. Table 1 is a comparison chart of the particle size, PDI value and ζ-potential changes of plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9.
[0103] Table 1 Average particle size, PDI and potential of different samples
[0104]
[0105] Note: Different letters in the same column indicate significant differences (P<0.5)
[0106] As can be seen from Table 1, after alkali-heat treatment, the particle size of the protein is significantly reduced because the protein is hydrolyzed during the alkali-heat treatment. The PDI of TSPI, TPPI, TCPI, TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG are smaller than that of SPI, PPI, CPI, SPI-EGCG, PPI-EGCG, and CPI-EGCG, respectively, indicating that the particle size distribution of TSPI, TPPI, TCPI, TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG is narrower, and the particle size of the sample is more uniform. After grafting with EGCG, the particle size of the sample increases because EGCG is grafted onto the protein surface. It is worth noting that the particle sizes of SPI-EGCG-MIX, PPI-EGCG-MIX, CPI-EGCG-MIX, TSPI-EGCG-MIX, TPPI-EGCG-MIX, and TCPI-EGCG-MIX are very large because EGCG can act as a ligand to connect different protein molecules at a higher concentration, resulting in the formation of protein aggregates. In terms of potential, the absolute values of the potentials of SPI-EGCG, PPI-EGCG, CPI-EGCG and TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG all showed an increasing trend compared with SPI, PPI, CPI and TSPI, TPPI, and TCPI. This is mainly because quinone substances carry negative charges in an alkaline environment and can combine with the positively charged groups of proteins, thereby enhancing the negative potential of the composite system and leading to an increase in the absolute potential. In addition, the absolute zeta potentials of SPI-EGCG, PPI-EGCG, CPI-EGCG and TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG all exceed 30 mV, which can prevent particle aggregation caused by electrostatic repulsion, suggesting their potential as effective emulsifiers.
[0107] 5. Surface hydrophobicity of the composite:
[0108] 8-anilino-1-naphthalenesulfonic acid (ANS) was used to measure the surface hydrophobicity (H0) of proteins. Different protein concentrations (0.04, 0.08, 0.12, 0.16 and 0.20 mg / mL) and ANS reagent (8 mM) were prepared with 0.01 M phosphate buffer (pH 7.0). 4 mL of protein (0.04-0.2 mg / mL) was mixed with 50 μL of ANS reagent (8 mM), and its fluorescence intensity was measured using a fluorescence spectrometer (RF-6000, Shimadzu, Japan). The excitation wavelength and emission wavelength were 365 nm and 484 nm, respectively. The relative fluorescence intensity of the sample refers to the fluorescence intensity of the sample minus the fluorescence intensity of the blank reagent. By plotting the relative fluorescence intensity of the sample against the protein concentration, the slope of the straight line can be obtained, which is the surface hydrophobicity index (H0).
[0109] Figure 4A-4C The surface hydrophobicity of the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9, Figure 4A Soy protein, Figure 4B For pea protein, Figure 4C Chickpea protein. Compared with SPI, PPI, and CPI, the surface hydrophobicity (H0) of TSPI, TPPI, and TCPI after alkali-heat treatment increased significantly. This is because the alkali-heat treatment caused partial hydrolysis of the protein to form protein hydrolysates, and its secondary structure stretched, resulting in the exposure of hydrophobic groups and regions to the more polar surrounding environment. However, the surface hydrophobicity index (H0) of the covalent complex and the physical mixture decreased significantly (p<0.05). This may be because (1) the hydrophilic hydroxyl group of EGCG was introduced; (2) the hydrophobic groups on the surface of the plant-based protein were covered; (3) the previously hidden hydrophilic groups of the plant-based protein were exposed.
[0110] 6. Solubility of the complex
[0111] The solubility of protein samples was determined by the Coomassie Brilliant Blue method. The sample was dissolved in deionized water to obtain a sample solution with a protein concentration of 3.0 mg / mL. The pH value of the solution was adjusted to 2-12 using 1M HCl and NaOH. The solution was stirred at a constant speed (300 rpm) for 30 min to ensure full dissolution. The sample was then centrifuged at 8000 rpm for 20 min. The protein content in the supernatant was determined by the Coomassie Brilliant Blue method. The ratio of the protein concentration in the supernatant to the total protein concentration is the solubility of the protein.
[0112] The solubility test was performed on the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9. The test results are as follows: Figure 5A-5C As shown, Figure 5A Soy protein, Figure 5B For pea protein, Figure 5C Chickpea protein. Since pea protein, soy protein and chickpea protein are all legume proteins, their main components are 11S globulin and 7S globulin, and the isoelectric points of 11S globulin and 7S globulin are between 4.5-5.2, it is observed that at pH 4.0, the solubility of SPI, PPI and CPI is the lowest. In the entire pH range, the solubility of TSPI, TPPI and TCPI is significantly higher than that of SPI, PPI and CPI, which is due to the partial hydrolysis of the protein during alkaline heat treatment. In addition, during the hydrolysis process, SPI, PPI and CPI expose more ionizable groups, further improving their solubility. After SPI, PPI and CPI form covalent complexes with EGCG, their solubility is significantly improved within the pH range studied, because the presence of polar EGCG phenolic hydroxyl groups enhances the hydrogen bonding between the complex and water molecules. In addition, it can be observed that the solubility of all physical mixtures (SPI-EGCG-MIX, PPI-EGCG-MIX, CPI-EGCG-MIX, TSPI-EGCG-MIX, TPPI-EGCG-MIX, TCPI-EGCG-MIX) is lower than that of the original protein samples (SPI, PPI, CPI, TSPI, TPPI, TCPI). This is because in the non-covalent complex, EGCG and protein are mainly bound through hydrophobic interactions and hydrogen bonds, acting as a bridge to aggregate protein molecules to form large protein aggregates, which reduces their solubility. It is worth noting that when the pH environment becomes alkaline, the solubility of the non-covalent complex increases. This is not only because when the pH value is alkaline, the surface charge density of the protein molecules increases and the hydrophilicity increases significantly, resulting in higher solubility, but also because when the pH is in an alkaline environment, the EGCG in the sample is oxidized into quinone, and some protein-EGCG non-covalent complexes and plant-based protein hydrolysate-EGCG non-covalent complexes become protein-EGCG non-covalent complexes and plant-based protein hydrolysate-EGCG complexes, and their solubility increases.
[0113] 7. Thermal stability of the complex
[0114] The thermal denaturation temperature and enthalpy of different freeze-dried samples were determined by differential scanning calorimetry analysis. 2.0 mg of freeze-dried sample was added to an aluminum pan and sealed, and an empty sealed aluminum pan was used as a blank control. The heating rate was set to 10°C / min, and the heating range was 40-180°C. The initial denaturation temperature, thermal denaturation temperature, and enthalpy of each sample were calculated according to the instrument analysis software.
[0115] The plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 were subjected to thermal stability tests. The test results are as follows: Figure 6A-6C As shown, Fig. 6A Soy protein, Figure 6B For pea protein, Figure 6C It is chickpea protein. All thermal analysis graphs show a broad endothermic peak, which is attributed to the thermal denaturation of protein subunits. The Td value is the peak thermal denaturation temperature, and a high value generally indicates that the globular protein has high thermal stability. After the protein is treated with alkaline heat, its denaturation temperature decreases, which may be due to the exposure of internal sulfhydryl or hydrophobic groups. After the protein is treated with alkaline heat, the compact structure of the protein supported by disulfide bonds is reduced, and as the protein hydrolysis proceeds, the peptide chain is broken and the energy required for complete denaturation continues to decrease. The protein-EGCG complex has better thermal stability due to the addition of EGCG, and the grafting with EGCG increases the denaturation temperature of the protein by 5.47℃-48.04℃. In addition, compared with protein-EGCG complexes (SPI-EGCG, PPI-EGCG, CPI-EGCG), plant-based protein hydrolysate-EGCG complexes (TSPI-EGCG, TPPI-EGCG, TCPI-EGCG) showed higher denaturation temperatures and better thermal stability, which may be related to the higher grafting degree of plant-based protein hydrolysate-EGCG complexes.
[0116] 8. Emulsifying activity of the complex:
[0117] Prepare a protein and protein-EGCG complex solution with a concentration of 5 mg / mL, then add 1.5 mL of medium-chain triglycerides (MCT), and homogenize the mixture at 15,000 rpm for 5 min at room temperature to form an emulsion. Take 40 μL of liquid from the bottom of the homogenate at 0 and 10 min, respectively, and dilute it 50 times with 0.1% SDS solution. Measure the absorbance of the sample at 500 nm and record it as A0, A1, A2, A3, A4, A5, A6, A7, A8, A9, A10, A11, A12, A13, A14, A15, A16, A17, A18, A19, A20, A21, A22, A23, A24, A36, A19, A25, A37, A38, A40, A59, A60, A7 10 The emulsifying activity (EAI) and emulsifying stability (ESI) of the samples were calculated according to the following formula. 0.1% SDS solution was used as a blank control.
[0118] EAI(m 2 / g) = (2 × 2.303 × A0) / (C × 10 4 ×Φ)×100
[0119] ESI(%)=A 10 / A0×100%
[0120] Among them, A0 and A 10 are the absorbance of the solutions taken out at 0 min and 10 min at 400 nm; C is the protein concentration (5 g / mL); Φ is the proportion of the oil phase (20%).
[0121] The plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 were tested for emulsification activity index (EAI) and emulsification stability index (ESI). The test results are as follows: Figure 7A-7C As shown, Fig. 7A Soy protein, Figure 7B For pea protein, Figure 7C for chickpea protein. The EAI of TSPI, TPPI, and TCPI increased significantly (p < 0.05) compared with SPI, PPI, and CPI, because the partial structural unfolding in the treated TSPI, TPPI, and TCPI samples led to increased exposure of the hydrophobic amino acid side chain groups, which allowed more oil droplets to be adsorbed, thereby obtaining greater surface activity.
[0122] Compared with SPI, PPI, CPI and TSPI, TPPI, TCPI, the EAI values of the covalent complexes (SPI-EGCG, PPI-EGCG, CPI-EGCG, TSPI-EGCG, TPPI-EGCG, TCPI-EGCG) increased, and the improvement in the emulsification properties of the complexes may be attributed to their increased water solubility, which is essential for good emulsification. In addition, the covalent attachment of hydrophilic EGCG to plant-based proteins may reduce the aggregation of oil droplets by increasing the steric repulsion between oil droplets. Compared with SPI-EGCG, PPI-EGCG, CPI-EGCG, TSPI-EGCG, TPPI-EGCG, TCPI-EGCG showed stronger emulsification properties, probably because it had the highest degree of grafting.
[0123] 9. Antioxidant activity of the complex:
[0124] The antioxidant capacity of the plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, plant-based protein hydrolysate-EGCG complex, plant-based protein-EGCG physical mixture, and plant-based protein hydrolysate-EGCG physical mixture in Examples 1-3 and Comparative Examples 1-9 was evaluated using the ABTS free radical scavenging method. The test results are as follows: Figure 8A-8C As shown, Fig. 8A Soy protein, Figure 8B For pea protein, Figure 8C Chickpea protein. Prepare ABTS working solution in advance and store it at room temperature away from light. Dilute the ABTS working solution with deionized water before analysis to make its absorbance 0.70±0.02. Pipette 1mL of sample solution into a centrifuge tube, add 3mL of diluted ABTS solution, mix well, and react at room temperature for 18 minutes in a dark place. Measure the absorbance at 734nm, and use deionized water instead of sample solution as a blank control. The formula for calculating ABTS free radical scavenging rate is as follows:
[0125] ABTS free radical scavenging activity (%) = (1-A m / A n )×100
[0126] Among them, A m is the absorbance of the sample at 734 nm, and An is the absorbance of the blank sample at 734 nm.
[0127] The plant-based proteins, plant-based protein hydrolysates, plant-based protein-EGCG complexes, plant-based protein hydrolysates-EGCG complexes, plant-based protein-EGCG physical mixtures, and plant-based protein hydrolysates-EGCG physical mixtures in Examples 1-3 and Comparative Examples 1-9 were tested for antioxidant activity. The results are shown in Table 1. Figure 8A-8C. Due to the grafting of EGCG, the protein-EGCG complex exhibited excellent antioxidant activity. Overall, the antioxidant activity of SPI, PPI, and CPI was relatively weak, while the antioxidant capacity of TSPI, TPPI, and TCPI was significantly lower than that of SPI, PPI, and CPI, which was mainly attributed to the fact that the heat treatment process significantly increased the formation of protein carbonyls, resulting in a decrease in its antioxidant capacity. Secondly, the antioxidant capacity of the covalent complexes SPI-EGCG, PPI-EGCG, CPI-EGCG and TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG was significantly improved (p<0.05). In addition, the antioxidant capacity of TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG was slightly stronger than that of SPI-EGCG, PPI-EGCG, and CPI-EGCG, which may be related to the higher grafting degree of TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG. Compared with TSPI, TPPI, TCPI and SPI, PPI, CPI, the antioxidant activity of TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG increased by 294%-350%, while that of SPI-EGCG, PPI-EGCG, and CPI-EGCG only increased by 208%-294%. This indicates that under the same conditions, due to the high binding rate of EGCG, TSPI-EGCG, TPPI-EGCG, and TCPI-EGCG have higher antioxidant activity than SPI-EGCG, PPI-EGCG, and CPI-EGCG.
[0128] 10. Emulsion flocculation index
[0129] The flocculation index (FI, %) of the fresh emulsion was calculated based on the D 43 The value is calculated using the following formula:
[0130] FI(%)=(D w / D s -1)×100
[0131] In the formula, D w D in distilled water 43 ;D s is D in 1% (w / v) SDS 43 .
[0132] The flocculation degree of the fresh emulsion was further evaluated by measuring the flocculation index. The particle size of the walnut oil emulsion stabilized by plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, and plant-based protein hydrolysate-EGCG complex in distilled water and 1% (w / v) SDS in Examples 1-3, Comparative Example 1, Comparative Example 4, and Comparative Example 7 was measured to evaluate the flocculation degree of the emulsion. The results are shown in Figure 9A-9I( Fig. 9A The average particle size of the emulsion stabilized by soybean protein samples in distilled water and 1% SDS. Fig. 9B This is the flocculation index diagram of soybean protein in distilled water and 1% SDS. Fig. 9C The particle size distribution diagram of soybean protein in distilled water and 1% SDS; Fig.9D This is the average particle size diagram of the emulsion stabilized by pea protein samples in distilled water and 1% SDS. Fig.9E This is the flocculation index diagram of pea protein in distilled water and 1% SDS. Fig.9F This is the particle size distribution diagram of pea protein in distilled water and 1% SDS; Figure 9G The average particle size of the chickpea protein sample stabilized emulsion in distilled water and 1% SDS. Figure 9H This is the flocculation index diagram of chickpea protein in distilled water and 1% SDS. Fig.9I is the particle size distribution diagram of chickpea protein in distilled water and 1% SDS). Fig. 9A , Fig.9D , Figure 9G As shown, it can be seen that for all types of plant proteins, the emulsions stabilized by the plant-based protein hydrolysate-EGCG complex have submicron-level emulsions, and compared with the emulsions stabilized by other emulsifiers, the emulsions stabilized by the plant-based protein hydrolysate-EGCG complex have the lowest particle size and the lowest flocculation index, indicating that the covalent binding of EGCG and plant-based protein hydrolysate can effectively reduce the flocculation degree of the emulsion. After dilution in SDS solution, except for the emulsion stabilized by the plant-based protein hydrolysate-EGCG complex, the droplet size of the emulsions stabilized by other emulsifiers was significantly reduced, indicating that the emulsions underwent severe reversible flocculation.
[0133] The particle size distribution of different emulsions was also evaluated and the results were as follows Fig. 9C , Fig.9F , Fig.9I As shown. When dispersed in distilled water, the emulsion exhibited a bimodal distribution. After dilution with SDS, the absorption peak height of the emulsion at 1 μm increased significantly. Therefore, the distribution peak of the original emulsion near the larger particle size was caused by the flocculation of the droplets. Compared with other complexes, the flocculation index of the plant-based protein hydrolysate-EGCG complex was the smallest, which was mainly due to the fact that the plant-based protein hydrolysate-EGCG complex after alkali-heat treatment had a stronger absolute value of potential, which could maintain the stability of the emulsion and inhibit its aggregation by providing steric repulsion and electrostatic interactions.
[0134] 11. Storage stability of emulsion
[0135] Take an appropriate amount of the emulsion and add it to a measuring bottle. Store it in a refrigerator at 4°C and record the appearance of the emulsion every other week.
[0136] The walnut oil emulsions stabilized by plant-based protein, plant-based protein hydrolysate, plant-based protein-EGCG complex, and plant-based protein hydrolysate-EGCG complex in Examples 1-3, Comparative Example 1, Comparative Example 4, and Comparative Example 7 were stored in a refrigerator at 4°C, and their emulsion morphologies were observed every week. The results are shown in Table 1. Fig.10 . Visually, all sample-stabilized emulsions were milky white at first, with no oil or water separation, indicating that the emulsions were relatively stable at this time. However, the emulsions stabilized by plant-based protein and plant-based protein hydrolysate experienced severe oil-water separation after 28 days of storage, and their aqueous phase was completely separated from the emulsions, while the emulsions stabilized by plant-based protein hydrolysate-EGCG complexes still maintained a good appearance after 28 days, and their emulsion morphology remained uniform. This is mainly because the plant-based protein hydrolysate-EGCG complex after alkali-heat treatment has a strong absolute value of potential, which can maintain the stability of the emulsion and inhibit its aggregation by providing spatial repulsion and electrostatic interactions.
[0137] In summary, the present invention provides a plant protein hydrolysate-EGCG complex and its stable anti-flocculation submicron emulsion preparation and application, including obtaining a plant-based protein hydrolysate by alkali heat treatment, introducing natural EGCG, and causing the plant-based protein hydrolysate to covalently react with EGCG by alkali induction to obtain a plant-based protein hydrolysate-EGCG complex, and the walnut oil emulsion stabilized by the plant-based protein hydrolysate-EGCG complex is a submicron emulsion, and has a lower flocculation index, which greatly improves its 4°C storage stability, and provides a new method for the preparation of a new food functional factor delivery carrier, which can improve the absorption efficiency of hydrophobic bioactive substances. In addition, the preparation method of the present invention is novel, the preparation process is simple, and it is easy to realize industrial production, and it has a wide range of uses in the fields of embedding of bioactive substances, delivery of nutrients, and controlled release of drugs.
[0138] In the present invention, soy protein, pea protein and chickpea protein are selected as raw materials. After only simple alkali heat treatment, the functional properties of these proteins such as solubility and emulsification activity are significantly improved. The plant-based protein hydrolysate-EGCG complex prepared by the present invention has significantly improved emulsification activity, solubility, thermal stability and antioxidant activity, providing a new method for the preparation of a new food functional factor delivery carrier. The emulsion stabilized by the prepared plant-based protein hydrolysate-EGCG complex is a submicron emulsion with a low flocculation index and good storage stability.
[0139] In addition, the inventors of this case also referred to the aforementioned embodiments and conducted experiments with other raw materials, process operations, and process conditions described in this specification, and obtained relatively ideal results.
[0140] It should be understood that the technical solution of the present invention is not limited to the above-mentioned specific implementation cases. Any technical deformation made according to the technical solution of the present invention without departing from the scope of protection of the purpose of the present invention and the claims shall fall within the protection scope of the present invention.
Claims
1. A method for preparing a deflocculated submicron emulsion, characterized in that: include: A mixed solution containing a plant-based protein hydrolysate-EGCG complex and water is used as the aqueous phase, and walnut oil is used as the oil phase; Furthermore, the oil phase is mixed with the water phase and subjected to shearing and high-pressure homogenization treatment to obtain a deflocculated submicron emulsion.
2. The preparation method according to claim 1, characterized in that: Specifically include: dispersing the plant-based protein hydrolysate-EGCG complex in water to form a plant-based protein hydrolysate-EGCG complex dispersion as an aqueous phase; Also, walnut oil as the oil phase is slowly added to the water phase under stirring conditions, and sheared at 8000-10000 rpm for 2-4 minutes, and then homogenized by a high-pressure homogenizer to obtain a deflocculated submicron emulsion.
3. The preparation method according to claim 2, characterized in that: The homogenization treatment conditions include: three fixed cycles at 40-60 MPa.
4. The preparation method according to claim 2, characterized in that: The concentration of the plant-based protein hydrolysate-EGCG complex in the plant-based protein hydrolysate-EGCG complex dispersion is 0.5 to 1.5 wt %; And / or, the volume ratio of the water phase to the oil phase is 95:5 to 85:
15.
5. The preparation method according to claim 1, characterized in that: The preparation method of the plant-based protein hydrolysate-EGCG complex comprises: The plant-based protein is subjected to a heat-alkali treatment to obtain a plant-based protein hydrolyzate; The plant-based protein hydrolysate is mixed with EGCG and subjected to an alkali induction treatment to obtain a plant-based protein hydrolysate-EGCG complex.
6. The preparation method according to claim 5, characterized in that: Specifically include: Dispersing the plant-based protein in water and stirring overnight to fully hydrate it to obtain a plant-based protein dispersion; and adjusting the pH value of the plant-based protein dispersion to 11.5-12.5, heating the dispersion to 75-85° C. in a water bath and maintaining the dispersion for 25-35 min, followed by cooling and adjusting the pH value to 6.5-7.5 to obtain a plant-based protein hydrolyzate; Preferably, the concentration of the plant protein in the plant-based protein dispersion is 0.5-1.5 w / v%; Preferably, the plant-based protein includes any one of soy protein isolate, pea protein isolate, and chickpea protein isolate.
7. The preparation method according to claim 5, characterized in that: Specifically include: The plant-based protein hydrolysate solution and the EGCG solution were mixed and the pH value was adjusted to 8.5-9.5, and the mixture was stirred at 200-400 rpm for 24 hours in the dark, and then purified and dried to obtain a plant-based protein hydrolysate-EGCG complex; Preferably, the volume ratio of the plant-based protein hydrolyzate solution to the EGCG solution is 10:2-10:4; Preferably, the particle size of the plant-based protein hydrolysate-EGCG complex is 0.588-1.266 μm; Preferably, the purification treatment is performed by dialysis, wherein the dialysis temperature is 4-8°C; the molecular weight of the dialysis bag used for dialysis is 8000-16000Da; Preferably, the drying process is performed by vacuum freeze drying.
8. The preparation method according to claim 5, characterized in that: The volume ratio of the plant-based protein to EGCG is 10:2-10:
4.
9. The anti-flocculation submicron emulsion prepared by the preparation method according to any one of claims 1 to 8.
10. Use of the deflocculated submicron emulsion according to claim 9 in liquid emulsified food.
Citation Information
Patent Citations
Preparation meted for high-stability soybean protein emulsion
CN104938765A
Method for preparing functional protein complex from aqueous enzymatic soybean hydrolysate
CN110547355A
Whey protein isolate-polyphenol compound stable oil-water interface emulsion as well as preparation method and application thereof
CN113045768A
Pea protein isolate-epigallocatechin gallate-iron ion ternary complex as well as preparation method and application thereof
CN116731525A
Zein covalent complex as well as preparation method and application thereof
CN117752091A
